Showing 1 - 8 results of 8 for search 'Joshua F Apgar', query time: 0.03s Refine Results
  1. 1
    Mechanistic PK/PD modeling to address early-stage biotherapeutic dosing feasibility questions

    Mechanistic PK/PD modeling to address early-stage biotherapeutic dosing feasibility questions by Joshuaine Grant, Fei Hua, Joshua F. Apgar, John M. Burke, Diana H. Marcantonio

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Quantitative systems pharmacology model of GITR‐mediated T cell dynamics in tumor microenvironment

    Quantitative systems pharmacology model of GITR‐mediated T cell dynamics in tumor microenvironment by Yan Ji, Kumpal Madrasi, Deborah A. Knee, Lore Gruenbaum, Joshua F. Apgar, John M. Burke, Bruce Gomes

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions

    Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions by Diana H. Marcantonio, Andrew Matteson, Marc Presler, John M. Burke, David R. Hagen, Fei Hua, Joshua F. Apgar

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Quantitative Systems Pharmacology Model of a Masked, Tumor‐Activated Antibody

    Quantitative Systems Pharmacology Model of a Masked, Tumor‐Activated Antibody by Mark Stroh, Jason Sagert, John M. Burke, Joshua F. Apgar, Lin Lin, Bjorn L. Millard, W. Michael Kavanaugh

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Comparison of dose selection based on target engagement versus inhibition of receptor-ligand interaction for checkpoint inhibitors

    Comparison of dose selection based on target engagement versus inhibition of receptor-ligand interaction for checkpoint inhibitors by Sarah A. Head, Carter Johnson, Saheli Sarkar, Andrew Matteson, Diana H. Marcantonio, Fei Hua, John M. Burke, Joshua F. Apgar, David Flowers

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer

    Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer by Hiroyuki Sayama, Diana Marcantonio, Takeyuki Nagashima, Masashi Shimazaki, Tsuyoshi Minematsu, Joshua F Apgar, John M. Burke, Lucia Wille, Yasuhisa Nagasaka, Daniel C. Kirouac

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloid

    Quantitative systems pharmacology model for Alzheimer's disease to predict the effect of aducanumab on brain amyloid by Lin Lin, Fei Hua, Cristian Salinas, Carissa Young, Thierry Bussiere, Joshua F. Apgar, John M. Burke, Kumar Kandadi Muralidharan, Rajasimhan Rajagovindan, Ivan Nestorov

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    A systems pharmacology model for gene therapy in sickle cell disease

    A systems pharmacology model for gene therapy in sickle cell disease by Bo Zheng, Lucia Wille, Karsten Peppel, David Hagen, Andrew Matteson, Jeffrey Ahlers, James Schaff, Fei Hua, Theresa Yuraszeck, Enoch Cobbina, Joshua F. Apgar, John M. Burke, John Roberts, Raibatak Das

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: